Literature DB >> 19332407

Retinopathy of prematurity: an eye toward better outcomes.

Charlene Pollan1.   

Abstract

Retinopathy of prematurity (ROP) results from the abnormal growth of blood vessels in the vascular bed supporting the developing retina. Estimated to cause up to 500 new cases of blindness in the U.S. each year, ROP affects primarily infants born at less than 1,500 g. Although its etiology is not well understood, ROP is thought to occur as a result of a complex interaction between oxygen and vascular growth factors. This article briefly reviews the history of ROP, discusses its pathophysiology, and addresses the risk factors and strategies for prevention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332407     DOI: 10.1891/0730-0832.28.2.93

Source DB:  PubMed          Journal:  Neonatal Netw        ISSN: 0730-0832


  4 in total

1.  Retinal nerve fiber layer thickness in prematurity is correlated with stage of retinopathy of prematurity.

Authors:  K-A Park; S Y Oh
Journal:  Eye (Lond)       Date:  2015-09-25       Impact factor: 3.775

2.  The matricellular protein cysteine-rich protein 61 (CCN1/Cyr61) enhances physiological adaptation of retinal vessels and reduces pathological neovascularization associated with ischemic retinopathy.

Authors:  Adeel Hasan; Nataliya Pokeza; Lynn Shaw; Hyun-Seung Lee; Douglas Lazzaro; Hemabindu Chintala; Daniel Rosenbaum; Maria B Grant; Brahim Chaqour
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

3.  Maintaining optimal oxygen saturation in premature infants.

Authors:  Yoke Yen Lau; Yih Yann Tay; Varsha Atul Shah; Pisun Chang; Khuan Tai Loh
Journal:  Perm J       Date:  2011

Review 4.  Arginase in retinopathy.

Authors:  S Priya Narayanan; Modesto Rojas; Jutamas Suwanpradid; Haroldo A Toque; R William Caldwell; Ruth B Caldwell
Journal:  Prog Retin Eye Res       Date:  2013-07-03       Impact factor: 21.198

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.